How the microbiota shapes rheumatic diseases

T Van de Wiele, JT Van Praet, M Marzorati… - Nature Reviews …, 2016 - nature.com
The human gut harbours a tremendously diverse and abundant microbial community that
correlates with, and even modulates, many health-related processes. The mucosal interfaces …

[HTML][HTML] Diagnosis of complement alternative pathway disorders

…, S Sethi, Y Zhang, RJ Smith, D Murray, J Van Praet… - Kidney international, 2016 - Elsevier
Kidney diseases resulting from abnormal control of the complement alternative pathway
include atypical hemolytic uremic syndrome, C3 glomerulonephritis, and dense-deposit disease…

Kidney disease caused by dysregulation of the complement alternative pathway: an etiologic approach

AS De Vriese, S Sethi, J Van Praet… - Journal of the …, 2015 - journals.lww.com
Kidney diseases caused by genetic or acquired dysregulation of the complement alternative
pathway (AP) are traditionally classified on the basis of clinical presentation (atypical …

Describing instruction set processors using nML

A Fauth, J Van Praet, M Freericks - Proceedings the European …, 1995 - ieeexplore.ieee.org
Programmable processors offer a high degree of flexibility and are therefore increasingly
being used in embedded systems. We introduce the formalism nML which is especially suited …

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

V Smith, JT Van Praet, B Vandooren… - Annals of the …, 2010 - ard.bmj.com
Objectives: The safety and potential efficacy of rituximab was examined in diffuse cutaneous
systemic sclerosis (dc-SSc). A 24 week open-label study in which eight patients with dc-SSc …

[PDF][PDF] The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity

…, S De Prijck, F Muskens, M Sze, J Van Praet… - Immunity, 2011 - cell.com
Dendritic cells (DCs) regulate both immunity and tolerance. Here we have shown that the
ubiquitin editing enzyme A20 (Tnfaip3) determines the activation threshold of DCs, via control …

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

…, C Berg Venemyr, J Van Praet… - Blood, The Journal …, 2022 - ashpublications.org
… Jens van Praet, Jens van Praet … Weinbergerová, Francesca Farina, Giulia Dragonetti,
Caroline Berg Venemyr, Jens van Praet, Ozren Jaksic, Toni Valković, Iker Falces-Romero, Sonia …

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

…, F Triest, N Van Goethem, J Van Praet… - International journal of …, 2020 - Elsevier
Hydroxychloroquine (HCQ) has been largely used and investigated as therapy for COVID-19
across various settings at a total dose usually ranging from 2400 mg to 9600 mg. In Belgium…

[HTML][HTML] Predictors and dynamics of the humoral and cellular immune response to SARS-CoV-2 mRNA vaccines in hemodialysis patients: a multicenter observational …

J Van Praet, M Reynders, D De Bacquer… - Journal of the …, 2021 - journals.lww.com
Background Preliminary evidence suggests patients on hemodialysis have a blunted early
serological response to SARS-CoV-2 vaccination. Optimizing the vaccination strategy in this …

Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study

…, F De Keyser, S Decuman, JT Van Praet… - Annals of the …, 2010 - ard.bmj.com
Objective Investigation of the reliability of the qualitative and semiquantitative scoring of
nailfold videocapillaroscopy (NVC) assessment between two raters in a systemic sclerosis (SSc) …